Treatment for chronic stable angina: A guidelines-based approach

Ythan Goldberg, Aron I. Schwarcz

Research output: Contribution to journalArticle

Abstract

Quality care in clinical cardiology, as in all of medicine, relies on the incorporation of evidence from clinical trials to help inform and drive management of patients. Stable ischemic heart disease (SIHD) presenting with stable angina is a common clinical scenario seen by internists and clinical cardiologists in multiple settings. The management of patients with chronic stable angina requires consideration of risk factors, comorbidities, symptoms, coronary anatomy, and ischemic burden. The physician has a variety of tools at his or her disposal, ranging from lifestyle modification and pharmacotherapy, to percutaneous and surgical procedures. The past two decades have witnessed an explosion in the amount of evidence that is currently available to inform the clinical care of these patients, which has led to the development and dissemination of clinical guidelines that have systematically assessed the different lifestyle, pharmacologic, and revascularization strategies in patients with SIHD. Patients with SIHD demonstrate higher rates of cardiovascular morbidity and mortality and, therefore, their management includes two distinct goals: to mitigate major cardiovascular mortality and morbidity and to reduce symptom burden. This article reviews the intersection of two of these guidelines: the recently published 2012 SIHD guidelines and the Appropriate Use Criteria for Revascularization, first published in 2009 and recently revised in 2012. The overlap between the two guidelines is discussed, as well as the gaps within them, particularly as they relate to the role of pharmacologic therapies, in an effort to build a case for evidence-based management of patients with SIHD.

Original languageEnglish (US)
JournalReviews in Cardiovascular Medicine
Volume14
Issue numberSUPPL.
DOIs
StatePublished - 2013

Fingerprint

Stable Angina
Myocardial Ischemia
Guidelines
Life Style
Morbidity
Therapeutics
Mortality
Explosions
Quality of Health Care
Cardiology
Comorbidity
Anatomy
Patient Care
Medicine
Clinical Trials
Physicians
Drug Therapy

Keywords

  • Appropriate use criteria
  • Guidelines-based management
  • Revascularization
  • Stable ischemic heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Treatment for chronic stable angina : A guidelines-based approach. / Goldberg, Ythan; Schwarcz, Aron I.

In: Reviews in Cardiovascular Medicine, Vol. 14, No. SUPPL., 2013.

Research output: Contribution to journalArticle

@article{4fcd184f140b460cbef0bf1d75b4131b,
title = "Treatment for chronic stable angina: A guidelines-based approach",
abstract = "Quality care in clinical cardiology, as in all of medicine, relies on the incorporation of evidence from clinical trials to help inform and drive management of patients. Stable ischemic heart disease (SIHD) presenting with stable angina is a common clinical scenario seen by internists and clinical cardiologists in multiple settings. The management of patients with chronic stable angina requires consideration of risk factors, comorbidities, symptoms, coronary anatomy, and ischemic burden. The physician has a variety of tools at his or her disposal, ranging from lifestyle modification and pharmacotherapy, to percutaneous and surgical procedures. The past two decades have witnessed an explosion in the amount of evidence that is currently available to inform the clinical care of these patients, which has led to the development and dissemination of clinical guidelines that have systematically assessed the different lifestyle, pharmacologic, and revascularization strategies in patients with SIHD. Patients with SIHD demonstrate higher rates of cardiovascular morbidity and mortality and, therefore, their management includes two distinct goals: to mitigate major cardiovascular mortality and morbidity and to reduce symptom burden. This article reviews the intersection of two of these guidelines: the recently published 2012 SIHD guidelines and the Appropriate Use Criteria for Revascularization, first published in 2009 and recently revised in 2012. The overlap between the two guidelines is discussed, as well as the gaps within them, particularly as they relate to the role of pharmacologic therapies, in an effort to build a case for evidence-based management of patients with SIHD.",
keywords = "Appropriate use criteria, Guidelines-based management, Revascularization, Stable ischemic heart disease",
author = "Ythan Goldberg and Schwarcz, {Aron I.}",
year = "2013",
doi = "10.3909/ricmS0002",
language = "English (US)",
volume = "14",
journal = "Reviews in Cardiovascular Medicine",
issn = "1530-6550",
publisher = "MedReviews LLC",
number = "SUPPL.",

}

TY - JOUR

T1 - Treatment for chronic stable angina

T2 - A guidelines-based approach

AU - Goldberg, Ythan

AU - Schwarcz, Aron I.

PY - 2013

Y1 - 2013

N2 - Quality care in clinical cardiology, as in all of medicine, relies on the incorporation of evidence from clinical trials to help inform and drive management of patients. Stable ischemic heart disease (SIHD) presenting with stable angina is a common clinical scenario seen by internists and clinical cardiologists in multiple settings. The management of patients with chronic stable angina requires consideration of risk factors, comorbidities, symptoms, coronary anatomy, and ischemic burden. The physician has a variety of tools at his or her disposal, ranging from lifestyle modification and pharmacotherapy, to percutaneous and surgical procedures. The past two decades have witnessed an explosion in the amount of evidence that is currently available to inform the clinical care of these patients, which has led to the development and dissemination of clinical guidelines that have systematically assessed the different lifestyle, pharmacologic, and revascularization strategies in patients with SIHD. Patients with SIHD demonstrate higher rates of cardiovascular morbidity and mortality and, therefore, their management includes two distinct goals: to mitigate major cardiovascular mortality and morbidity and to reduce symptom burden. This article reviews the intersection of two of these guidelines: the recently published 2012 SIHD guidelines and the Appropriate Use Criteria for Revascularization, first published in 2009 and recently revised in 2012. The overlap between the two guidelines is discussed, as well as the gaps within them, particularly as they relate to the role of pharmacologic therapies, in an effort to build a case for evidence-based management of patients with SIHD.

AB - Quality care in clinical cardiology, as in all of medicine, relies on the incorporation of evidence from clinical trials to help inform and drive management of patients. Stable ischemic heart disease (SIHD) presenting with stable angina is a common clinical scenario seen by internists and clinical cardiologists in multiple settings. The management of patients with chronic stable angina requires consideration of risk factors, comorbidities, symptoms, coronary anatomy, and ischemic burden. The physician has a variety of tools at his or her disposal, ranging from lifestyle modification and pharmacotherapy, to percutaneous and surgical procedures. The past two decades have witnessed an explosion in the amount of evidence that is currently available to inform the clinical care of these patients, which has led to the development and dissemination of clinical guidelines that have systematically assessed the different lifestyle, pharmacologic, and revascularization strategies in patients with SIHD. Patients with SIHD demonstrate higher rates of cardiovascular morbidity and mortality and, therefore, their management includes two distinct goals: to mitigate major cardiovascular mortality and morbidity and to reduce symptom burden. This article reviews the intersection of two of these guidelines: the recently published 2012 SIHD guidelines and the Appropriate Use Criteria for Revascularization, first published in 2009 and recently revised in 2012. The overlap between the two guidelines is discussed, as well as the gaps within them, particularly as they relate to the role of pharmacologic therapies, in an effort to build a case for evidence-based management of patients with SIHD.

KW - Appropriate use criteria

KW - Guidelines-based management

KW - Revascularization

KW - Stable ischemic heart disease

UR - http://www.scopus.com/inward/record.url?scp=84879071276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879071276&partnerID=8YFLogxK

U2 - 10.3909/ricmS0002

DO - 10.3909/ricmS0002

M3 - Article

AN - SCOPUS:84879071276

VL - 14

JO - Reviews in Cardiovascular Medicine

JF - Reviews in Cardiovascular Medicine

SN - 1530-6550

IS - SUPPL.

ER -